Supplemental material
Open access
1,887
Views
7
CrossRef citations to date
0
Altmetric
Research Paper
Synthesis and biological evaluation of novel (E)-N'-benzylidene hydrazides as novel c-Met inhibitors through fragment based virtual screening
Jing-wei LiangSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Shi-long LiSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Shan WangSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Wan-qiu LiSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
& Fan-hao MengSchool of Pharmacy, China Medical University, Shen Yang, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 468-477
|
Received 13 Sep 2019, Accepted 02 Dec 2019, Published online: 06 Jan 2020
Related Research Data
Safety and Tolerability of c-MET Inhibitors in Cancer
Source:
Springer Science and Business Media LLC
A comprehensive view of the structure and expression of the ependymoma genome
Source:
Oxford University Press (OUP)
Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors.
Source:
Informa UK Limited
Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion.
Source:
Impact Journals, LLC
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Source:
American Association for Cancer Research (AACR)
Development of novel ACK1/TNK2 inhibitors using a fragment-based approach
Source:
American Chemical Society (ACS)
EGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem Cells
Source:
Elsevier BV
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Source:
American Association for Cancer Research (AACR)
Discovery of potent 1H-imidazo[4,5-b]pyridine-based c-Met kinase inhibitors via mechanism-directed structural optimization
Source:
Elsevier BV
c-Met: Structure, functions and potential for therapeutic inhibition
Source:
Springer Science and Business Media LLC
Synthesis and anti-tumor activity of [1,4] dioxino [2,3-f] quinazoline derivatives as dual inhibitors of c-Met and VEGFR-2.
Source:
Elsevier BV
Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors.
Source:
Elsevier BV
Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.
Source:
American Chemical Society (ACS)
Sample Preparation
Source:
Wiley
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.